180 Life Sciences Corp. (ATNF)
Automate Your Wheel Strategy on ATNF
With Tiblio's Option Bot, you can configure your own wheel strategy including ATNF - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ATNF
- Rev/Share 0.0
- Book/Share 2.1771
- PB 0.3969
- Debt/Equity 0.0193
- CurrentRatio 1.0221
- ROIC -0.8086
- MktCap 4922040.0
- FreeCF/Share -0.3675
- PFCF -3.7836
- PE -0.4096
- Debt/Assets 0.0127
- DivYield 0
- ROE -1.4734
- Rating B
- Score 3
- Recommendation Neutral
- P/E Score 1
- DCF Score 5
- P/B Score 5
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
Published: May 01, 2025 by: Accesswire
Sentiment: Neutral
PALO ALTO, CA / ACCESS Newswire / May 1, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences" or the "Company"), an innovative media and entertainment company focused on the global iGaming sector, with certain legacy biotechnology intellectual property assets, today announced that the United States Patent and Trademark Office ("USPTO") has issued an official Notice of Allowance for U.S. Patent Application No. 17/556,584, covering a novel method for preventing or reducing Post-Operative Cognitive Dysfunction ("POCD").
Read More
180 Life Sciences Corp. Announces Share Repurchase
Published: April 30, 2025 by: Accesswire
Sentiment: Neutral
PALO ALTO, CALIFORNIA / ACCESS Newswire / April 30, 2025 / 180 Life Sciences Corp. (NASDAQ:ATNF) ("180 Life Sciences," the "Company," "we," or "us") today announced that it has entered into a Settlement and Mutual Release Agreement (the "Agreement") with Elray Resources, Inc. ("Elray") and Luxor Capital, LLC ("Luxor"). The Agreement strengthens and simplifies the Company's capital structure through a significant repurchase of shares.
Read More
About 180 Life Sciences Corp. (ATNF)
- IPO Date 2017-06-27
- Website https://180lifesciences.com
- Industry Biotechnology
- CEO Mr. Lloyd Blair Jordan L.L.B., M.B.A.
- Employees 4